The trading price of ClearPoint Neuro Inc (NASDAQ:CLPT) closed lower on Friday, May 23, and closing at $11.89, -1.57% lower than its previous close.
In examining the 52-week price action we see that the stock hit a 52-week high of $19.22 and a 52-week low of $5.11. Over the past month, the stock has lost -16.79% in value.
ClearPoint Neuro Inc, whose market valuation is $336.07 million at the time of this writing, is expected to release its quarterly earnings report in June. Investors’ optimism about the company’s current quarter earnings report is understandable.
On the technical side, indicators suggest CLPT has a Hold on average for the short term. According to the data of the stock’s medium term indicators, the stock is currently averaging as a 100% Sell, while an average of long term indicators suggests that the stock is currently 50% Sell.
A quick review shows that CLPT’s price is currently -11.65% off the SMA20 and -7.77% off the SMA50. The RSI metric on the 14-day chart is currently showing 40.22, and weekly volatility stands at 1.89%. When measured over the past 30 days, the indicator reaches 4.38%. ClearPoint Neuro Inc (NASDAQ:CLPT)’s beta value is currently sitting at 0.97, while the Average True Range indicator is currently displaying 0.90. With analysts defining $30-$30 as the low and high price targets, we arrive at a consensus price target of $30 for the trailing 12-month period. The current price is about -152.31% off the estimated low and -152.31% off the forecast high, based on this estimate. Investors will be thrilled if CLPT’s share price rises to $30, which is the median consensus price. At that level, CLPT’s share price would be -152.31% below current price.
To see how ClearPoint Neuro Inc stock has been performing in comparison to its peers in the industry, here are the numbers: CLPT stock’s performance was -1.57% in the latest trading, and 95.88% in the past year.
An evaluation of the daily trading volume of ClearPoint Neuro Inc (NASDAQ:CLPT) indicates that the 3-month average is 278.68K.
Currently, records show that 27.98 million of the company’s shares remain outstanding. The insiders hold 14.46% of outstanding shares, whereas institutions hold 29.35%. However, since the stock’s price has seen -22.69% year-to-date, investors’ interest is likely to be reignited due to its potential to move even lower.
